Cargando…
Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
Diabetic macular edema (DME) is the most common cause of visual impairment among patients with diabetes mellitus. Anti-vascular endothelial growth factors (Anti-VEGFs) are considered the first line in its management. The aim of this research has been to develop a deep learning (DL) model for predict...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870773/ https://www.ncbi.nlm.nih.gov/pubmed/35204404 http://dx.doi.org/10.3390/diagnostics12020312 |
_version_ | 1784656838415876096 |
---|---|
author | Alryalat, Saif Aldeen Al-Antary, Mohammad Arafa, Yasmine Azad, Babak Boldyreff, Cornelia Ghnaimat, Tasneem Al-Antary, Nada Alfegi, Safa Elfalah, Mutasem Abu-Ameerh, Mohammed |
author_facet | Alryalat, Saif Aldeen Al-Antary, Mohammad Arafa, Yasmine Azad, Babak Boldyreff, Cornelia Ghnaimat, Tasneem Al-Antary, Nada Alfegi, Safa Elfalah, Mutasem Abu-Ameerh, Mohammed |
author_sort | Alryalat, Saif Aldeen |
collection | PubMed |
description | Diabetic macular edema (DME) is the most common cause of visual impairment among patients with diabetes mellitus. Anti-vascular endothelial growth factors (Anti-VEGFs) are considered the first line in its management. The aim of this research has been to develop a deep learning (DL) model for predicting response to intravitreal anti-VEGF injections among DME patients. The research included treatment naive DME patients who were treated with anti-VEGF. Patient’s pre-treatment and post-treatment clinical and macular optical coherence tomography (OCT) were assessed by retina specialists, who annotated pre-treatment images for five prognostic features. Patients were also classified based on their response to treatment in their post-treatment OCT into either good responder, defined as a reduction of thickness by >25% or 50 µm by 3 months, or poor responder. A novel modified U-net DL model for image segmentation, and another DL EfficientNet-B3 model for response classification were developed and implemented for predicting response to anti-VEGF injections among patients with DME. Finally, the classification DL model was compared with different levels of ophthalmology residents and specialists regarding response classification accuracy. The segmentation deep learning model resulted in segmentation accuracy of 95.9%, with a specificity of 98.9%, and a sensitivity of 87.9%. The classification accuracy of classifying patients’ images into good and poor responders reached 75%. Upon comparing the model’s performance with practicing ophthalmology residents, ophthalmologists and retina specialists, the model’s accuracy is comparable to ophthalmologist’s accuracy. The developed DL models can segment and predict response to anti-VEGF treatment among DME patients with comparable accuracy to general ophthalmologists. Further training on a larger dataset is nonetheless needed to yield more accurate response predictions. |
format | Online Article Text |
id | pubmed-8870773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88707732022-02-25 Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS) Alryalat, Saif Aldeen Al-Antary, Mohammad Arafa, Yasmine Azad, Babak Boldyreff, Cornelia Ghnaimat, Tasneem Al-Antary, Nada Alfegi, Safa Elfalah, Mutasem Abu-Ameerh, Mohammed Diagnostics (Basel) Article Diabetic macular edema (DME) is the most common cause of visual impairment among patients with diabetes mellitus. Anti-vascular endothelial growth factors (Anti-VEGFs) are considered the first line in its management. The aim of this research has been to develop a deep learning (DL) model for predicting response to intravitreal anti-VEGF injections among DME patients. The research included treatment naive DME patients who were treated with anti-VEGF. Patient’s pre-treatment and post-treatment clinical and macular optical coherence tomography (OCT) were assessed by retina specialists, who annotated pre-treatment images for five prognostic features. Patients were also classified based on their response to treatment in their post-treatment OCT into either good responder, defined as a reduction of thickness by >25% or 50 µm by 3 months, or poor responder. A novel modified U-net DL model for image segmentation, and another DL EfficientNet-B3 model for response classification were developed and implemented for predicting response to anti-VEGF injections among patients with DME. Finally, the classification DL model was compared with different levels of ophthalmology residents and specialists regarding response classification accuracy. The segmentation deep learning model resulted in segmentation accuracy of 95.9%, with a specificity of 98.9%, and a sensitivity of 87.9%. The classification accuracy of classifying patients’ images into good and poor responders reached 75%. Upon comparing the model’s performance with practicing ophthalmology residents, ophthalmologists and retina specialists, the model’s accuracy is comparable to ophthalmologist’s accuracy. The developed DL models can segment and predict response to anti-VEGF treatment among DME patients with comparable accuracy to general ophthalmologists. Further training on a larger dataset is nonetheless needed to yield more accurate response predictions. MDPI 2022-01-26 /pmc/articles/PMC8870773/ /pubmed/35204404 http://dx.doi.org/10.3390/diagnostics12020312 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alryalat, Saif Aldeen Al-Antary, Mohammad Arafa, Yasmine Azad, Babak Boldyreff, Cornelia Ghnaimat, Tasneem Al-Antary, Nada Alfegi, Safa Elfalah, Mutasem Abu-Ameerh, Mohammed Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS) |
title | Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS) |
title_full | Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS) |
title_fullStr | Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS) |
title_full_unstemmed | Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS) |
title_short | Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS) |
title_sort | deep learning prediction of response to anti-vegf among diabetic macular edema patients: treatment response analyzer system (tras) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870773/ https://www.ncbi.nlm.nih.gov/pubmed/35204404 http://dx.doi.org/10.3390/diagnostics12020312 |
work_keys_str_mv | AT alryalatsaifaldeen deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT alantarymohammad deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT arafayasmine deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT azadbabak deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT boldyreffcornelia deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT ghnaimattasneem deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT alantarynada deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT alfegisafa deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT elfalahmutasem deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras AT abuameerhmohammed deeplearningpredictionofresponsetoantivegfamongdiabeticmacularedemapatientstreatmentresponseanalyzersystemtras |